Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Pacira BioSciences Presents Updated Three-Year Data On PCRX-201 Gene Therapy In Patients With Moderate-to-Severe Osteoarthritis Of The Knee, Showing Clinical Improvements For Up To 156 Weeks Following Single Administration

Author: Benzinga Newsdesk | October 28, 2025 07:13am

Posted In: PCRX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist